Jörg Emmrich Selected Research

Jörg Emmrich Research Topics

6	Fibrosis (Cirrhosis) 02/2009 - 09/2005
5	Chronic Pancreatitis 02/2009 - 05/2002
4	Inflammation (Inflammations) 03/2010 - 01/2003
2	Neoplasms (Cancer) 02/2009 - 10/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2008 - 04/2007
2	Liver Diseases (Liver Disease) 09/2008 - 03/2007
2	Pancreatitis 10/2006 - 01/2003
1	Disease Progression 02/2009
1	Bacterial Infections (Bacterial Infection) 10/2008
1	Liver Failure 09/2008
1	Acute-On-Chronic Liver Failure 09/2008
1	Ulcerative Colitis 09/2007
1	End Stage Liver Disease 03/2007
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2007
1	Pathologic Processes 01/2003

4	dibutyldichlorotinIBA 03/2010 - 05/2002
3	CytokinesIBA 10/2008 - 01/2003
2	EnzymesIBA 10/2008 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 10/2008 - 01/2003
2	AlbuminsIBA 09/2008 - 03/2007
1	Bosentan (Tracleer)FDA Link 02/2009
1	Endothelin A ReceptorIBA 02/2009
1	Lysine (L-Lysine)FDA Link 10/2008
1	ImmunosorbentsIBA 10/2008
1	BenzodiazepinesIBA 09/2008
1	dansylsarcosineIBA 09/2008
1	Extracellular Matrix ProteinsIBA 04/2007
1	InterleukinsIBA 10/2006
1	Complementary DNA (cDNA)IBA 10/2006
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 10/2005
1	LectinsIBA 10/2005
1	Interleukin-4 (Interleukin 4)IBA 09/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2003
1	RNA (Ribonucleic Acid)IBA 01/2003
1	TrypsinIBA 01/2003
1	Interferon-gamma (Interferon, gamma)IBA 01/2003
1	estropipate (Ogen)FDA LinkGeneric 01/2003
1	Amylases FDA Link 01/2003
1	high density lipoprotein binding proteinIBA 01/2003
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2002

1	Immunotherapy 10/2008
1	Therapeutics 09/2007